Does aspirin have an effect on risk of death in patients with COVID-19? A meta-analysis

PURPOSE: The coronavirus disease 2019 (COVID-19) pandemic has shown unprecedented impact world-wide since the eruption in late 2019. Importantly, emerging reports suggest an increased risk of thromboembolism development in patients with COVID-19. Meanwhile, it is found that aspirin reduced mortality...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Shaodi, Su, Wanying, Sun, Chenyu, Lowe, Scott, Zhou, Zhen, Liu, Haixia, Qu, Guangbo, Xia, Weihang, Xie, Peng, Wu, Birong, Gao, Juan, Feng, Linya, Sun, Yehuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217117/
https://www.ncbi.nlm.nih.gov/pubmed/35732963
http://dx.doi.org/10.1007/s00228-022-03356-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217117/
https://www.ncbi.nlm.nih.gov/pubmed/35732963
http://dx.doi.org/10.1007/s00228-022-03356-5

Ejemplares similares